CHU Rennes
Rennes, France
Location status: Recruiting
Location contact
Eric Geffray
CONTACT
NCT Number: NCT05763186
An increasing number of patients are receiving central lines, including PiccLine systems for the administration of therapeutics and nutrition.
Although these systems are not theoretically intended for blood collection, nurses prefer them as a puncture site when they are in place in their patients, saving them from further peripheral puncture in people who generally do not have optimal venous capital.
It is essential to purge the tubing in place in the patient and filled with infusion solution before drawing blood. Although the dead volume of the tubing used does not exceed 2mL, the volume of purging required before filling tubes for the laboratory appears to be much greater. Anecdotal evidence suggests a useful volume of 20ml but this has never been clearly demonstrated. In addition, the Biochemistry laboratory regularly sees blood samples diluted with perfusion solution, as evidenced by biochemical assays, leading to the cancellation of analyses received in the laboratory and a new sample being taken. This increases blood spoliation for these often already anaemic patients.
There is no consensus in the literature on recommendations for such sampling in PiccLine patients:
* The CLSI1 (Clinical and Laboratory Standart Institute), a non-governmental organisation, issued sampling recommendations in 2017 that were taken up by Becton Dickinson2, a supplier of blood collection tubes. These recommendations include:
* Rinse with 10 ml of 0.9% NaCl * Then a purge of 3 to 11 ml (depending on the analysis sought) * English-language articles3,4,5,6,7 show purge volumes ranging from 3 to 6 ml with significantly different sampling methods (rinsing or not).
The investigators therefore note a discrepancy between the sampling practices of the university hospital and the recommendations of the CLSI. In fact, the investigators noted a lack of rinsing prior to purging, which could explain the difference between 20 and 3 ml. This raises the issue of protocolisation of this type of sampling in order to standardise practices.
A consultation of other hospitals, carried out beforehand, enabled us to note that French practices are not in agreement with these recommendations. The management of the Rennes University Hospital as well as the Haute Autorité de Santé were contacted in order to confirm that no normative document had been published or was being drafted on this subject.
The fields of study are: sampling practices on PiccLine, the pre-analytical phase in medical biology.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Rennes, France
Location status: Recruiting
Eric Geffray
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comparison of the results of the biological examinations obtained on the 6 tubes collected on the PiccLine with the results of the biological examinations obtained on the peripheral sample.
Comparison of the results of the biological examinations obtained on the 6 tubes collected on the PiccLine with the results of the biological examinations obtained on the peripheral sample.
Time frame: during 2 days follow-up
Contact information is provided by the study sponsor or research team.
Anne Ganivet
CONTACT
Nicolas Mevel
CONTACT
Rennes University Hospital
Other
The Right Amount of Purge Useful for Blood Sampling on PiccLine
Acronym: PiccLine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06840756
Cardiovascular, Critically Ill Intensive Care Unit Patients
Hamilton, Ontario, Canada
View Trial DetailsNCT07372690
Fatigue, Hematology
Torino, TO, Italy
View Trial DetailsNCT06007794
Atrophy, Cancer
Pierre-Bénite, France
View Trial DetailsNCT04931329
Hematology, Medical Oncology
Limoges, France
View Trial Details